Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer
Recruiting
Observational Study
Cervix Cancer
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 90
- Sex
- Female
- Study type
- Observational
- Participants needed
- 1,800 (estimated)
- Sponsor
- Tata Memorial Hospital · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Retrospective study utilizing patient data to develop and validate Machine Learning application. Available imaging data sets of patients who have completed treatment will be used to develop Normal tissue complication probability and Tumour control probability
Hypothesis Integrating existing radiation treatment information, quantitative imaging and patient outcome data from completed and ongoing c…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
For Aim 1 and Aim 3:
* Patients treated within ongoing and completed clinical trials of chemoradiation and brachytherapy for cervix cancer with access to MRI/CT images at the time of diagnosis and brachytherapy For Aim 2
* Patients undergoing postoperative or definitive radioth…
Contacts